29.11.2012 Views

Type 2 Diabetes Adult Outpatient Insulin Guidelines - CMA Foundation

Type 2 Diabetes Adult Outpatient Insulin Guidelines - CMA Foundation

Type 2 Diabetes Adult Outpatient Insulin Guidelines - CMA Foundation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical Management of Dyslipidemia 9,31,32,33<br />

Addressing dyslipidemia is a key component in preventing long term cardiovascular disease in<br />

individuals with type 2 diabetes. Many patients with diabetes have elevated cholesterol values,<br />

which can lead to greater risk of developing cardiovascular disease or acute cardiovascular events.<br />

Diabetic dyslipidemia is a recognizable and modifiable patient risk factor that should be identified<br />

and treated early to prevent complications.<br />

Published by the National Heart Lung and Blood Institute (NHLBI), the ATP III guidelines are an<br />

evidence-based set of recommendations that focus on intensive cholesterol-lowering therapy. The<br />

guidelines address the primary prevention of coronary heart disease (CHD) in persons with multiple<br />

risk factors by managing elevated patient cholesterol levels to reach goal. The ATP III <strong>Guidelines</strong><br />

At-a-Glance Quick Desk Reference which outlines the step by step sequence of cholesterol<br />

management has been provided. The NHLBI and the American <strong>Diabetes</strong> Association recommend<br />

prescribing lifestyle modifications and cholesterol lowering medications to reach the following<br />

target (optimal) adult cholesterol levels:<br />

Targeting <strong>Adult</strong> Cholesterol Levels<br />

Table TABLe 23: Classification 23 Classification of Lipid of Lipid Profile Risk<br />

LDL Cholesterol – Primary Target of Therapy (mg/dL)<br />

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!